17q21 asthma-risk variants switch CTCF binding and regulate IL-2 production by T cells

Citations Over TimeTop 10% of 2016 papers

Abstract

Asthma and autoimmune disease susceptibility has been strongly linked to genetic variants in the 17q21 haploblock that alter the expression of ORMDL3; however, the molecular mechanisms by which these variants perturb gene expression and the cell types in which this effect is most prominent are unclear. We found several 17q21 variants overlapped enhancers present mainly in primary immune cell types. CD4+ T cells showed the greatest increase (threefold) in ORMDL3 expression in individuals carrying the asthma-risk alleles, where ORMDL3 negatively regulated interleukin-2 production. The asthma-risk variants rs4065275 and rs12936231 switched CTCF-binding sites in the 17q21 locus, and 4C-Seq assays showed that several distal cis-regulatory elements upstream of the disrupted ZPBP2 CTCF-binding site interacted with the ORMDL3 promoter region in CD4+ T cells exclusively from subjects carrying asthma-risk alleles. Overall, our results suggested that T cells are one of the most prominent cell types affected by 17q21 variants.

Related Papers

• → CTCF shapes chromatin structure and gene expression in health and disease(2022)110 cited
• → Systematic screening of CTCF binding partners identifies that BHLHE40 regulates CTCF genome-wide distribution and long-range chromatin interactions(2020)45 cited
• → MYC reshapes CTCF-mediated chromatin architecture in prostate cancer(2023)33 cited
• → Inferring CTCF-binding patterns and anchored loops across human tissues and cell types(2023)6 cited
• → Vertebrate Protein CTCF and its Multiple Roles in a Large-Scale Regulation of Genome Activity(2009)29 cited